,41,42,43 Our findings indicate that this specific population of MYH11+αSMA+ CAFs may also exist in patients with advanced NSCLC, potentially adversely affecting the TME by recruiting Treg cells. Here, MYH11 is linked to non-small cell lung carcinoma.